144 related articles for article (PubMed ID: 34799997)
1. Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer.
Wang B; Chen S; Xiao H; Zhang J; Liang D; Shan J; Zou H
Cancer Med; 2022 Jan; 11(1):268-280. PubMed ID: 34799997
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of complete blood count parameters in advanced-stage lung cancer patients.
Rojko L; Megyesfalvi Z; Czibula E; Reiniger L; Teglasi V; Szegedi Z; Szallasi Z; Dome B; Moldvay J
Thorac Cancer; 2020 Nov; 11(11):3193-3204. PubMed ID: 32941706
[TBL] [Abstract][Full Text] [Related]
3. Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.
Fujimoto D; Ueda H; Shimizu R; Kato R; Otoshi T; Kawamura T; Tamai K; Shibata Y; Matsumoto T; Nagata K; Otsuka K; Nakagawa A; Otsuka K; Katakami N; Tomii K
Clin Exp Metastasis; 2014 Jun; 31(5):543-51. PubMed ID: 24682604
[TBL] [Abstract][Full Text] [Related]
4. Mutational characteristics of bone metastasis of lung cancer.
Huang X; Shi X; Huang D; Li B; Lin N; Pan W; Yan X; Li H; Hao Q; Ye Z
Ann Palliat Med; 2021 Aug; 10(8):8818-8826. PubMed ID: 34488370
[TBL] [Abstract][Full Text] [Related]
5. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E;
Clin Colorectal Cancer; 2020 Sep; 19(3):e110-e116. PubMed ID: 32278676
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical features and gene mutations in non-small cell lung cancer with osteoblastic bone metastasis.
Takahara Y; Nakase K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Mizuno S
Cancer Treat Res Commun; 2021; 28():100440. PubMed ID: 34325210
[TBL] [Abstract][Full Text] [Related]
7. Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
Dormieux A; Mezquita L; Cournede PH; Remon J; Tazdait M; Lacroix L; Rouleau E; Adam J; Bluthgen MV; Facchinetti F; Tselikas L; Aboubakar F; Naltet C; Lavaud P; Gazzah A; Le Pechoux C; Lassau N; Balleyguier C; Planchard D; Besse B; Caramella C
Eur Radiol; 2020 Sep; 30(9):5021-5028. PubMed ID: 32323012
[TBL] [Abstract][Full Text] [Related]
8. Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer.
Zhou Y; Chen WZ; Peng AF; Tong WL; Liu JM; Liu ZL
Tumour Biol; 2017 Jul; 39(7):1010428317714194. PubMed ID: 28671048
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors.
Li XY; Zhu XR; Zhang CC; Yu W; Zhang B; Shen TL; Zhang HY; Fu XL
Clin Lung Cancer; 2020 Nov; 21(6):534-544. PubMed ID: 32505632
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan.
Guan J; Chen M; Xiao N; Li L; Zhang Y; Li Q; Yang M; Liu L; Chen L
Med Oncol; 2016 Jan; 33(1):1. PubMed ID: 26589606
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between circulating tumor cells and coagulation factors in primary lung cancer patients].
Liu CH; Gong P; Yang J
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):368-71. PubMed ID: 27188610
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis?
Mansuet-Lupo A; Zouiti F; Alifano M; Tallet A; Charpentier MC; Ducruit V; Devez F; Lemaitre F; Laurent-Puig P; Damotte D; Blons H
J Transl Med; 2014 May; 12():131. PubMed ID: 24885034
[TBL] [Abstract][Full Text] [Related]
15. The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.
Avsar M; Tambas M; Yalniz Z; Akdeniz D; Tuncer SB; Kilic S; Sukruoglu Erdogan O; Ciftci R; Dagoglu N; Vatansever S; Yazici H
Mol Biol Rep; 2019 Aug; 46(4):4001-4008. PubMed ID: 31069614
[TBL] [Abstract][Full Text] [Related]
16. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Hendriks LE; Smit EF; Vosse BA; Mellema WW; Heideman DA; Bootsma GP; Westenend M; Pitz C; de Vries GJ; Houben R; Grünberg K; Bendek M; Speel EJ; Dingemans AM
Lung Cancer; 2014 Apr; 84(1):86-91. PubMed ID: 24529684
[TBL] [Abstract][Full Text] [Related]
17. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
19. The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study.
Zhang J; Yu Q; He Y; Hu T; Chen K; Yang Z; Zhang X; Cheng D; He Z
Technol Cancer Res Treat; 2021; 20():15330338211036528. PubMed ID: 34378452
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
